Atlas Trials

Evaluate the Safety and Efficacy of Bremelanotide in Women With Female Sexual Arousal Disorder (FSAD)

Clinical trial NCT00425256 · COMPLETED

Trial details

NCT number
NCT00425256
Sponsor
Palatin Technologies, Inc
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Sexual Arousal Disorder
Start date
2006-02-01
Primary completion
2007-05-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.